Department of Interventional Cardiology, Papworth Hospital, Cambridge CB23 3RE, UK.
Eur Heart J. 2013 Feb;34(6):422-6. doi: 10.1093/eurheartj/ehs462. Epub 2013 Jan 2.
Patients presenting with acute coronary syndromes (ACS) remain amongst the highest-risk of all acute medical admissions. Despite significant reductions in morbidity and mortality via refinements in treatment methods in recent years, such individuals remain at a high risk of recurrent ischaemic events and death. Whilst 2012 has brought a wealth of novel data in the field of ACS regarding diagnosis and both medical and invasive management strategies, continued focus on this high-risk patient subset is necessary to further our understanding and improve patient outcomes.
患有急性冠状动脉综合征(ACS)的患者仍然是所有急性内科住院患者中风险最高的人群之一。尽管近年来通过改进治疗方法,发病率和死亡率显著降低,但此类患者仍有发生再次缺血事件和死亡的高风险。虽然 2012 年在 ACS 的诊断以及药物和介入治疗策略领域带来了大量新数据,但继续关注这一高危患者亚组对于进一步了解和改善患者结局是必要的。